Cookie technology helps us bring you the best possible experience when you visit this website. Please let us know if you're happy to accept cookies. To learn more about our policy on cookies, please review our privacy policy via the link at the bottom of the page.

en:

    • {%buzitemName%}
        {%buzbrandMenuItems%}
    • {%bitemName%} {%barrowSpan%}
        {%bsubBrandMenuItems%}
    • {%sbitemName%} {%sbarrowSpan%}
        {%sbproductMenuItems%}
    • {%pitemKeyName%} {%pitemBadges%} {%parrowSpan%}
      {%pselfProduct%}
    • {%mNavitemName%}
      • {%lScountries%}
    • {%allMenuItem%}
      • {%cSlanguages%}







      • DRY EYE DISEASE

      MULTIMEDIA

      Eye_Care_Medical_4


      2nd I-Care for MEAR Summit:






      Dry eye: Definition, mechanism, and diagnostic algorithm
      (Dr. Ivana Romac)








      Success in DED treatment/ DED follow-up visit/ monitor the progress
      (Dr. Islam Hamdi)









      Dry eye guidelines and algorithms p1-1
      (Dr. Mark Milner)








      Dry eye guidelines and algorithms p2-1
      (Dr. Mark Milner)









      Bo recipe for DED management/customize your own approach
      (Dr. Wassim Al Troudi)

      ABBV-BH-00115-MC




       

      Our therapy areas
      Oncology
      Immunology
      Medical Information
       
      Additional info
      Privacy Notice
      Terms Of Use

       

      For Oman HCPs.

      Department of Pharmacovigilance & Drug information.

      Directorate General of pharmaceutical affairs and Drug control.

      Ministry of health, Sultanate of Oman

      Phone Nos:: 22357687 / 22357686

      Fax: 22358489

      Email: [email protected]

      Website:www.moh.gov.om

       

      This website is intended for Gulf Healthcare Professionals

      AbbVie Biopharmaceuticals GmbH.

       

      Suite 2901, U Bora Tower,Business Bay, Dubai, UAE

      PO Box:: 118052

      OFFICE : +971 4 5506100

      FAX: +971 4 5506101

      Patient Safety is our Priority, we will remain always by your side. For Reporting Adverse events Please Contact.

      [email protected] or Hotline: 00971564135746